Photon Technology Internationalsaid it signed a research and development agreement with &lt;M-LTechnology Ventures L.P.>, a research and development limitedpartnership sponsored by Merrill Lynch Capital Markets   The agreement calls for MLTV to pay Photon more than 3.1 mlndlrs over a three-year period to develop new electro-opticaltechnologies with applications in the medical field, thecompany said.    In 1988, MLTV may, at its option, have the right to acquirewarrants to purchase, during the next six years, 475,000 sharesof the company's common stock at 6.50 dlrs per share, adjustedfor future earnings, Photon said. Reuter&#3;